🎯 Your Growth is Our Priority – India’s Trusted PCD Pharma Company
✅ WHO-GMP Certified 🛡️ Monopoly Rights 📢 Attractive Promotional Support 📦 Wide Product Range 💰 High Profit Margin
seen from Japan

seen from United States
seen from United States
seen from Türkiye
seen from Ireland

seen from United Kingdom

seen from United States
seen from China
seen from China

seen from United States
seen from United States

seen from United Kingdom

seen from Belgium
seen from Yemen

seen from Brazil
seen from Estonia

seen from Brazil
seen from Russia
seen from Croatia
seen from Türkiye
🎯 Your Growth is Our Priority – India’s Trusted PCD Pharma Company
✅ WHO-GMP Certified 🛡️ Monopoly Rights 📢 Attractive Promotional Support 📦 Wide Product Range 💰 High Profit Margin
🌱 Grow with Biocorp Lifesciences – India’s Trusted PCD Pharma Franchise Company
✅ WHO-GMP Certified 🛡️ Monopoly Rights 📢 Attractive Promotional Support 📦 Wide Product Range 💰 High Profit Margin
💊 Tablets | Capsules | Syrups | Injectables | Ointments
🧬✨ Biocorp LIFE SCIENCES wishes you a very Happy Navratri 2026! ✨🧬 On this auspicious occasion, may Maa Durga fill your life with strength, prosperity, and happiness. May her divine power inspire you to achieve new heights in life and science. Wishing you a blessed Navratri! 🙏🌸
More diversification on the horizon for Novo Nordisk
Corporate strategy involves ways to expand and diversify the business to create value. This may occur through mergers, acquisitions, and/or internal developments. While these strategies aren't without pitfalls, related or unrelated diversification can enhance shareholder value.
In early June, Novo Nordisk announced exclusive negotiations to acquire a controlling stake in BIOCORP. They would accomplish this purchasing stock from BIO JAG valued at approximately 154 million euros. Last week, BIOCORP followed up with an announcement that an agreement had been reached with Novo Nordisk obtaining 43.5% of its share capital and 62.2% of its voting rights. Novo Nordisk will now file a mandatory tender offer for remaining shares with the French Financial Market Authority.
So who's BIOCORP, and why is Novo Nordisk investing in them? Essentially, they are a company that develops and manufacturers devices and medication delivery systems. Their pharmaceutical device line includes delivery devices under development for both patient and pharmacy or manufacturer use. Their connected device line includes Bluetooth enabled technologies to track medication utilization technique and adherence data.
Acquiring BIOCORP is an "related" acquisition for Novo Nordisk. While you may primarily think of Novo Nordisk as a pharmaceutical manufacturer, they are also involved in the development and sale of delivery devices including injection pens for the medication they develop and the NovoPen smart devices. Acquiring BIOCORP comes with acquiring their innovations and existing R&D, and may create value by accelerating Novo Nordisk's growth in the medical device space.
Con mi baby's #BioCorp 🤗 Felices fiestas... 🌲🎅🤶⛄❄️ (en La Rosa Náutica) https://www.instagram.com/p/B6USqq9FDUU/?igshid=1ouhrfp3elmq5
Sales and Marketing Team
Our production department is the full-blown department which contains qualified quality engineers, logistics and dispatch team. They also help you with state transport compliance documentation required to ship your products. We also ensure that you receive the ordered product in a well-packed shipper so as to avoid any damage during the transportation process. Read More
Best PCD pharma franchise
We have dedicated teams for Sales, Marketing, logistics and finance. Our qualified QC experts monitor the production, batch sizes and quality deliverable.
PCD Pharma Franchise in India
PCD Pharma Franchise in India BIOCORP LIFE SCIENCES PVT. LTD, offers you a comprehensive range of WHO quality products. BIOCORP LIFE SCIENCES a leading ISO 9001:2015 Certified PCD Franchise Company, with more than 25 years of pharmaceutical experience on board. We bring you the best quality products in best possible pricing.